Live from the NIH registry
Studies recruiting near Huntington right now
Top 25 of 55 recruiting studies, sorted by proximity — each links to its official registry page
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: Children's Oncology Group
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: SWOG Cancer Research Network
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: NRG Oncology
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Local Institution - Unk064 — Huntington, West Virginia (0.8 mi)
· Sponsor: Mirati Therapeutics Inc.
Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation
Lung Cancer Screening
N/A
Interventional 330 participants sought
King's Daughter's Medical Center — Ashland, Kentucky (12.0 mi)
· Sponsor: Timothy Mullett
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Chronic Migraine in Children
Phase 3
Interventional 285 participants sought
Marshall Health-Marshall University Medical Center — Huntington, West Virginia (0.8 mi)
· Sponsor: H. Lundbeck A/S
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
Glioblastoma, IDH-Wildtype
Phase 2
Interventional 100 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Hepatitis
Phase 3
Interventional 350 participants sought
Marshall Health — Huntington, West Virginia (0.8 mi)
· Sponsor: Bausch Health Americas, Inc.
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
King's Daughter's Medical Center — Ashland, Kentucky (12.0 mi)
· Sponsor: NRG Oncology
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2
Interventional 146 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: Children's Oncology Group
Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
Systolic Hypertension, Pregnancy Related
N/A
Observational 60 participants sought
Maternal Hypertension Center at Cabell Huntington Hospital — Huntington, West Virginia (0.8 mi)
· Sponsor: Marshall University
IBS Skin Patch Test Food Allergy Study
Irritable Bowel Syndrome
N/A
Interventional 250 participants sought
Shepherd Allergy — Barboursville, West Virginia (7.6 mi)
· Sponsor: IBS-80, LLC
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: NRG Oncology
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Neoplasms, Arteriovenous Malformation of Central Nervous System
N/A
Observational 50,000 participants sought
St. Mary's Medical Center — Huntington, West Virginia (0.8 mi)
· Sponsor: The Radiosurgery Society
Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace
Anterior Cruciate Ligament Rupture
N/A
Observational 450 participants sought
Marshall University — Huntington, West Virginia (0.8 mi)
· Sponsor: Marshall University
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2
Interventional 56 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: SWOG Cancer Research Network
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8
Phase 2
Interventional 2,900 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention
Lung Cancer Screening
N/A
Interventional 35,500 participants sought
King's Daughter's Medical Center — Ashland, Kentucky (12.0 mi)
· Sponsor: Timothy Mullett
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2
Interventional 66 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: SWOG Cancer Research Network
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: NRG Oncology
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Multiple conditions
Phase 3
Interventional 1,780 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: Children's Oncology Group
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
King's Daughter's Medical Center — Ashland, Kentucky (12.0 mi)
· Sponsor: NRG Oncology